Biocon Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026 the market records a net outflow from foreign institutional investors (FII) of ₹ 3,111.94 Cr in cash, while domestic institutional investors (DII) inject a net ₹ 8,930.12 Cr. The contrasting directions underscore a shift in capital sentiment, with foreign participants pulling back and domestic players stepping in. For Biocon Limited (BIOCON) specifically, there were no block or bulk transactions reported, indicating that the broader cash‑flow dynamics are not being translated into sizable trades on the stock today.
Trend vs 5‑Day Average
Today's FII cash outflow exceeds the five‑day average net outflow of ₹ 3,333.81 Cr, suggesting a marginally softer foreign stance than has been typical over the past week. Conversely, the DII cash inflow of ₹ 8,930.12 Cr is slightly above its five‑day average of ₹ 4,430.43 Cr, reinforcing the pattern of growing domestic appetite.
F&O Positioning Data
FII participants hold a net long position of ₹ 374,795 Cr in futures‑and‑options (F&O) contracts, reflecting a bullish tilt in derivative markets. Their index‑futures positioning shows a long‑to‑short ratio of 1.2, indicating a modest preference for long exposures over short ones.
Healthcare Sector Flow
The healthcare segment, to which Biocon belongs, has experienced a recent net inflow from domestic institutions while foreign investors have been net sellers, mirroring the broader market flow patterns observed today.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04